Serotonin and Noradrenaline Reuptake Inhibitors
"Serotonin and Noradrenaline Reuptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.
Descriptor ID |
D000068760
|
MeSH Number(s) |
D27.505.519.562.437.693 D27.505.519.625.600.693 D27.505.696.577.600.693
|
Concept/Terms |
Serotonin and Noradrenaline Reuptake Inhibitors- Serotonin and Noradrenaline Reuptake Inhibitors
- SSRIs and NRIs
- NRIs and SSRIs
- Serotonin and Noradrenaline Uptake Inhibitors
- SNRIs
- Serotonin and Norepinephrine Reuptake Inhibitors
- Serotonin and Norepinephrine Uptake Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Serotonin and Noradrenaline Reuptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin and Noradrenaline Reuptake Inhibitors".
This graph shows the total number of publications written about "Serotonin and Noradrenaline Reuptake Inhibitors" by people in this website by year, and whether "Serotonin and Noradrenaline Reuptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin and Noradrenaline Reuptake Inhibitors" by people in Profiles.
-
Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy. 2023 07; 43(7):675-690.
-
Ramsey LB, Bishop JR, Strawn JR. Pharmacogenetics of treating pediatric anxiety and depression. Pharmacogenomics. 2019 08; 20(12):867-870.
-
Montan? Jaime LK, Paul J, Lalla A, Legall G, Gaedigk A. Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder. Pharmacogenomics. 2018 02; 19(3):197-212.
-
Patel P, Leeder JS, Piquette-Miller M, Dupuis LL. Aprepitant and fosaprepitant drug interactions: a systematic review. Br J Clin Pharmacol. 2017 Oct; 83(10):2148-2162.